David T. has a diverse background in clinical research and project management. With experience ranging from coordinating clinical trials to leading development programs, David has held various roles in reputable companies such as Scribe Therapeutics, Graphite Bio, and Genentech. David has also served on advisory boards and as a caregiver, showcasing a well-rounded skill set and dedication to various roles within the healthcare and biotech industry. Graduating with a Bachelor of Science in Exercise Biology from the University of California, Davis, David brings a strong educational background to complement their professional experience.
March 1, 2024 - present
March, 2023